DEFINIUM THERAPEUTICS INC
Q2 2026 13F Holders
Symbol
DFTX
CUSIP
24477V105
Type
Equity
Class
COM SHS
Num filings
391
Total reported value, excl. options
$5.48 B
Compare 2026 Q2 to
2026 Q3
2026 Q1
2025 Q4
Manager
Report Date
Value ($000)
Shares
Option Type